![Nvidia Q2 results top estimates; unveils $50B stock buyback](https://i-invdn-com.investing.com/news/moved_small-LYNXNPEK330I8_L.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.700 | 2.590 | 0.890 |
Convertible | 94.560 | 94.560 | 0.000 |
Preferred | 3.730 | 3.730 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 24.655 | 16.844 |
Price to Book | 3.360 | 1.661 |
Price to Sales | 5.038 | 2.195 |
Price to Cash Flow | 20.338 | 9.954 |
Dividend Yield | 2.514 | 1.307 |
5 Years Earnings Growth | 8.780 | 11.020 |
Number of long holdings: 67
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Axon Enterprise Inc 0.5% | - | 2.76 | - | - | |
Umicore S.A. 0% | BE6322623669 | 2.62 | - | - | |
Federal Home Loan Banks 0% | - | 2.59 | - | - | |
Cellnex Telecom S.A.U 0.5% | XS2021212332 | 2.55 | - | - | |
Apollo Global Management Inc 6.75% PRF CONVERT 31/07/2026 USD 50 - Ser A | - | 2.53 | - | - | |
Glencore Funding LLC 0% | XS1799614232 | 2.45 | - | - | |
Ivanhoe Mines Ltd. 2.5% | - | 2.45 | - | - | |
Burlington Stores Inc. 1.25% | - | 2.41 | - | - | |
Schneider Electric SE 1.97% | FR001400M9F9 | 2.24 | - | - | |
Neurocrine Biosciences Inc 2.25% | - | 2.21 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU0441901922 | 1.08B | 2.79 | -2.51 | -1.06 | ||
Franklin European Total Return Funu | 1.24M | -2.49 | -7.35 | -0.80 | ||
LU0889566138 | 10.27M | 0.26 | 0.83 | 2.03 | ||
Franklin U.S. Government Fund A acc | 82.57M | -2.06 | -3.86 | -0.26 | ||
Franklin US Government Fund X acc U | 1.23K | -0.44 | -2.43 | 1.03 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review